ALCMI looks forward to launching many new innovative projects next year to advance our research initiatives, including the Epidemiologic Features in Young People with Lung Cancer, a follow-up to our Genomics of Young Lung Study, and our Biospecimen Big Data Project.
As a follow-up to our Genomics of Young Lung Study, we plan to examine the Epidemiologic Features in Young People with Lung Cancer to understand the unique pathology and drivers of this disease in those under 40 years of age. We also look forward to launching our Biospecimen Big Data Project to create a centralized repository of donated patient tissue, blood, etc. and patient-reported information housed under one data umbrella. This first-of-its-kind data bank would allow patients and clinicians, regardless of where they live, to participate and opt-in to share information to help determine effective treatments, standard of care, and to establish a platform for patients to share their experiences. Another exciting collaboration involves clinical development of an anti-cancer vaccine that essentially “trains” a given patient’s immune system to potentially recognize and target his/her specific cells. These are just a sampling of the many innovative initiatives under development, in partnership and with the support of the Bonnie J. Addario Lung Cancer Foundation.
CALL TO ACTION: Learn more about these important new initiatives by contacting [email protected].